All Phenotypes Il6st<tm1Ern> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Il6st^tm1Ern
targeted mutation 1, Matthias Ernst
MGI:2388478

Summary

12 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Il6st^tm1Ern/Il6st^tm1Ern	involves: 129S1/Sv	MGI:4939802
hm2	Il6st^tm1Ern/Il6st^tm1Ern	involves: 129S1/Sv * C57BL/6	MGI:3837032
cn3	Il6st^tm1Ern/Il6st^tm1Wme Tg(Alb1-cre)7Gsc/?	involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * FVB/N	MGI:3837205
cx4	Il6st^tm1Ern/Il6st^tm1Ern Stat3^tm1Aki/Stat3⁺	involves: 129P2/OlaHsd * 129S1/Sv	MGI:3837309
cx5	Il6st^tm1Ern/Il6st^tm1Ern Tirap^tm1.1Pjh/Tirap^tm1.1Pjh	involves: 129S1/Sv	MGI:4939800
cx6	Il6st^tm1Ern/Il6st^tm1Ern Stat1^tm1Rds/Stat1^tm1Rds	involves: 129S1/Sv	MGI:3837310
cx7	Ifnar2^tm1Pjh/Ifnar2^tm1Pjh Il6st^tm1Ern/Il6st^tm1Ern	involves: 129S1/Sv	MGI:4939801
cx8	Il6^tm1Kopf/Il6^tm1Kopf Il6st^tm1Ern/Il6st^tm1Ern	involves: 129S1/Sv * 129S2/SvPas	MGI:3837308
cx9	Il6st^tm1Ern/Il6st⁺ Smad3^tm1Par/Smad3⁺	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:3837663
cx10	Il6st^tm1Ern/Il6st^tm1Ern Tg(RP11-H2112)9Trme/0	involves: 129S1/Sv * C57BL/6J * DBA/2J	MGI:5898092
cx11	Il6st^tm1Ern/Il6st^tm1Ern Tg(RP11-H2112)5Trme/0	involves: 129S1/Sv * C57BL/6J * DBA/2J	MGI:5898091
cx12	Gkn2^{tm1.1(KOMP)Vlcg}/Gkn2^{tm1.1(KOMP)Vlcg} Il6st^tm1Ern/Il6st^tm1Ern	involves: 129S1/Sv * C57BL/6NTac	MGI:5898089

Allelic Composition	Il6st^tm1Ern/Il6st^tm1Ern
Genetic Background	involves: 129S1/Sv

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

increased susceptibility to xenobiotic induced morbidity/mortality ( J:168781 )

• mice fail to survive beyond 72 hours after treatment with an LPS dose that is sub-lethal to wild-type mice

immune system

increased neutrophil cell number ( J:168781 )

• LPS-treated mice exhibit a 4-fold increase in neutrophil influx into the peritoneal cavity with a 2-fold increase in the neutrophil-attractant CXCL11 compared with similarly treated wild-type mice

increased circulating interleukin-6 level ( J:168781 )

• LPS-treated mice exhibit a 3.5- and 2-fold (at 3 and 6 hours) increase in serum IL6 levels compared with similarly treated wild-type mice

increased interleukin-6 secretion ( J:168781 )

• LPS-treated mice exhibit a 3- and 34-fold (at 3 and 6 hours) increase in IL6 at the site of injection compared with similarly treated wild-type mice

increased susceptibility to endotoxin shock ( J:168781 )

• LPS-treated mice exhibit an increase in serum IL6 (3.5-fold at 3 hours, 2-fold at 6 hours), IL6 secretion into the peritoneal cavity (3-fold at 3 hours, 32-fold at 6 hours), neutrophil infiltration into the peritoneal cavity, and increased mortality compared with similarly treated wild-type mice

• however, LPS-induced IL10 production is normal

homeostasis/metabolism

increased circulating interleukin-6 level ( J:168781 )

• LPS-treated mice exhibit a 3.5- and 2-fold (at 3 and 6 hours) increase in serum IL6 levels compared with similarly treated wild-type mice

increased susceptibility to xenobiotic induced morbidity/mortality ( J:168781 )

• mice fail to survive beyond 72 hours after treatment with an LPS dose that is sub-lethal to wild-type mice

hematopoietic system

increased neutrophil cell number ( J:168781 )

Allelic Composition	Il6st^tm1Ern/Il6st^tm1Ern
Genetic Background	involves: 129S1/Sv * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

digestive/alimentary system

abnormal small intestine morphology ( J:79073 )

• age dependent enlargement of the proximal small intestine starting around 6-8 weeks of age

abnormal stomach morphology ( J:79073 )

abnormal stomach mucosa morphology ( J:79073 , J:87206 )

• hyperproliferative lesions in the antropyloric mucosa (J:79073)

• gastric outlet obstruction (J:79073)

• fewer mucus producing cells (J:79073)

• enlarged glandular structure with increased branching (J:79073)

• infiltrating lymphocytes abundant in the lamina propria and intraepithelial compartments (J:79073)

• non adenomatous stomach is hyperplastic with more pronounced rugae (J:87206)

• total area is increased from 16 weeks of age onward (J:87206)

enlarged stomach ( J:79073 )

• age dependent enlargement starting around 6-8 weeks of age

abnormal digestive system physiology ( J:87206 )

decreased susceptibility to induced colitis ( J:79073 )

• completely resistant to 3.5% dextran sodium sulfate

increased stomach pH ( J:87206 )

• in mice over 20 weeks of age

stomach inflammation ( J:87206 )

• gastritis is seen in all adults

• mixed mononuclear cells and polymorphonuclear leukocytes involved

immune system

enlarged spleen ( J:79073 )

• age dependent enlargement starting around 6-8 weeks of age

increased osteoclast cell number ( J:87612 )

abnormal inflammatory response ( J:139226 )

• neutrophil infiltration of the peritoneal cavity peaks more rapidly in induced inflammation than in controls (6 vs 12 hrs)

• neutrophils cleared more rapidly than in controls in induced inflammation

decreased susceptibility to induced colitis ( J:79073 )

• completely resistant to 3.5% dextran sodium sulfate

stomach inflammation ( J:87206 )

• gastritis is seen in all adults

• mixed mononuclear cells and polymorphonuclear leukocytes involved

increased susceptibility to induced arthritis ( J:142883 )

• increased overall severity of arthritis induced with methylated bovine serum albumin

homeostasis/metabolism

decreased physiological sensitivity to xenobiotic ( J:79073 )

• completely resistant to 3.5% dextran sodium sulfate

neoplasm

increased adenoma incidence ( J:79073 , J:87206 )

• presence of pseudopolyploid diffuse adenomatous lesions in the stomach (J:79073)

• become larger and more numerous with age (J:87206)

• involve dysplastic cells and branching tortuous gastric glands (J:87206)

skeleton

increased osteoclast cell number ( J:87612 )

increased susceptibility to induced arthritis ( J:142883 )

• increased overall severity of arthritis induced with methylated bovine serum albumin

decreased compact bone thickness ( J:87612 )

increased osteoblast cell number ( J:87612 )

• on trabecular bone surfaces

abnormal trabecular bone morphology ( J:87612 )

• trabecular numbers reduced, particularly in males

decreased trabecular bone thickness ( J:87612 )

• trabecular thickness reduced, particularly in males

hematopoietic system

enlarged spleen ( J:79073 )

• age dependent enlargement starting around 6-8 weeks of age

increased osteoclast cell number ( J:87612 )

growth/size/body

enlarged spleen ( J:79073 )

• age dependent enlargement starting around 6-8 weeks of age

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
stomach cancer		DOID:10534	OMIM:613659	J:87206

Allelic Composition	Il6st^tm1Ern/Il6st^tm1Wme Tg(Alb1-cre)7Gsc/?
Genetic Background	involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)
Il6st^tm1Wme mutation (2 available); any Il6st mutation (80 available)
Tg(Alb1-cre)7Gsc mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

liver/biliary system

liver/biliary system phenotype ( J:97327 )

N	• do not suffer liver damage from ConA treatment if pretreated with Il6

abnormal liver regeneration ( J:135290 )

• maximal DNA synthesis in hepatocytes after partial hepatectomy occurs after about 48 hours

• hepatocyte growth factor has no effect on hepatocyte proliferation unless administered with Il6

Allelic Composition	Il6st^tm1Ern/Il6st^tm1Ern Stat3^tm1Aki/Stat3⁺
Genetic Background	involves: 129P2/OlaHsd * 129S1/Sv

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)
Stat3^tm1Aki mutation (6 available); any Stat3 mutation (70 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

mortality/aging ( J:100160 )

N	• improved survival

immune system

immune system phenotype ( J:100160 , J:139226 , J:142883 )

N	• splenomegaly fails to develop (J:100160) • neutrophil infiltration of the peritoneal cavity and subsequent clearance in induced inflammation normal (J:139226) • response to arthritis induced with methylated serum albumin is comparable to control animals (J:142883)

decreased circulating interleukin-6 level ( J:168781 )

• in LPS-treated mice compared with similarly treated Il6st^tm1Ern homozygotes

decreased susceptibility to endotoxin shock ( J:168781 )

• compared with LPS-treated Il6st^tm1Ern homozygotes

digestive/alimentary system

digestive/alimentary phenotype ( J:100160 )

N	• stomach size remains normal

neoplasm

neoplasm ( J:100160 )

N	• numbers of gastric adenomas is reduced

homeostasis/metabolism

decreased circulating interleukin-6 level ( J:168781 )

• in LPS-treated mice compared with similarly treated Il6st^tm1Ern homozygotes

Allelic Composition	Il6st^tm1Ern/Il6st^tm1Ern Tirap^tm1.1Pjh/Tirap^tm1.1Pjh
Genetic Background	involves: 129S1/Sv

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)
Tirap^tm1.1Pjh mutation (0 available); any Tirap mutation (15 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

decreased circulating interleukin-6 level ( J:168781 )

• in LPS-treated mice compared with similarly treated Il6st^tm1Ern homozygotes

decreased susceptibility to endotoxin shock ( J:168781 )

• LPS-treated mice exhibit increased survival and decreased serum IL6 compared with similarly treated Il6st^tm1Ern homozygotes

homeostasis/metabolism

decreased circulating interleukin-6 level ( J:168781 )

• in LPS-treated mice compared with similarly treated Il6st^tm1Ern homozygotes

Allelic Composition	Il6st^tm1Ern/Il6st^tm1Ern Stat1^tm1Rds/Stat1^tm1Rds
Genetic Background	involves: 129S1/Sv

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)
Stat1^tm1Rds mutation (4 available); any Stat1 mutation (72 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

abnormal inflammatory response ( J:139226 )

• neutrophil infiltration of the peritoneal cavity peaks more rapidly in induced inflammation than in controls

• neutrophils cleared more rapidly than in controls in induced inflammation

Allelic Composition	Ifnar2^tm1Pjh/Ifnar2^tm1Pjh Il6st^tm1Ern/Il6st^tm1Ern
Genetic Background	involves: 129S1/Sv

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ifnar2^tm1Pjh mutation (4 available); any Ifnar2 mutation (42 available)
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

increased susceptibility to xenobiotic induced morbidity/mortality ( J:168781 )

• mice fail to survive beyond 72 hours after treatment with an LPS dose that is sub-lethal to wild-type mice

immune system

increased circulating interleukin-6 level ( J:168781 )

• in LPS-treated mice

increased susceptibility to endotoxin shock ( J:168781 )

• mice fail to survive beyond 72 hours after treatment with an LPS dose that is sub-lethal to wild-type mice

• LPS-treated mice exhibit an increase in IL6 serum levels compared with similarly treated wild-type mice

homeostasis/metabolism

increased circulating interleukin-6 level ( J:168781 )

• in LPS-treated mice

increased susceptibility to xenobiotic induced morbidity/mortality ( J:168781 )

• mice fail to survive beyond 72 hours after treatment with an LPS dose that is sub-lethal to wild-type mice

Allelic Composition	Il6^tm1Kopf/Il6^tm1Kopf Il6st^tm1Ern/Il6st^tm1Ern
Genetic Background	involves: 129S1/Sv * 129S2/SvPas

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)
Il6^tm1Kopf mutation (9 available); any Il6 mutation (37 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

immune system phenotype ( J:139226 )

N	• neutrophil infiltration of the peritoneal cavity and subsequent clearance in induced inflammation normal

decreased susceptibility to endotoxin shock ( J:168781 )

• mice are resistant to LPS-induced shock

Allelic Composition	Il6st^tm1Ern/Il6st⁺ Smad3^tm1Par/Smad3⁺
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)
Smad3^tm1Par mutation (2 available); any Smad3 mutation (18 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased adenoma incidence ( J:100160 )

• develop antral adenomas by 13-24 weeks of age

Allelic Composition	Il6st^tm1Ern/Il6st^tm1Ern Tg(RP11-H2112)9Trme/0
Genetic Background	involves: 129S1/Sv * C57BL/6J * DBA/2J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)
Tg(RP11-H2112)9Trme mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

digestive/alimentary system

abnormal stomach mucosa morphology ( J:234656 )

• decrease in the overall thickness of the antral mucosa compared to mice homozygous for the Il6st mutation not carrying the transgene

decreased stomach tumor incidence ( J:234656 )

• decrease in antral tumor growth compared to mice homozygous for the Il6st mutation not carrying the transgene suggesting overexpression of GNK2 as a possible therapy for gastric cancer

hematopoietic system

abnormal spleen size ( J:234656 )

• decrease in the splenomegaly phenotype typically seen in mice homozygous for the Il6st mutation not carrying the transgene

neoplasm

decreased stomach tumor incidence ( J:234656 )

• decrease in antral tumor growth compared to mice homozygous for the Il6st mutation not carrying the transgene suggesting overexpression of GNK2 as a possible therapy for gastric cancer

immune system

abnormal spleen size ( J:234656 )

• decrease in the splenomegaly phenotype typically seen in mice homozygous for the Il6st mutation not carrying the transgene

Allelic Composition	Il6st^tm1Ern/Il6st^tm1Ern Tg(RP11-H2112)5Trme/0
Genetic Background	involves: 129S1/Sv * C57BL/6J * DBA/2J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)
Tg(RP11-H2112)5Trme mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

digestive/alimentary system

abnormal stomach mucosa morphology ( J:234656 )

• decrease in the overall thickness of the antral mucosa compared to mice homozygous for the Il6st mutation not carrying the transgene

decreased stomach tumor incidence ( J:234656 )

• decrease in antral tumor growth compared to mice homozygous for the Il6st mutation not carrying the transgene suggesting overexpression of GNK2 as a possible therapy for gastric cancer

hematopoietic system

abnormal spleen size ( J:234656 )

• decrease in the splenomegaly phenotype typically seen in mice homozygous for the Il6st mutation not carrying the transgene

neoplasm

decreased stomach tumor incidence ( J:234656 )

• decrease in antral tumor growth compared to mice homozygous for the Il6st mutation not carrying the transgene suggesting overexpression of GNK2 as a possible therapy for gastric cancer

immune system

abnormal spleen size ( J:234656 )

• decrease in the splenomegaly phenotype typically seen in mice homozygous for the Il6st mutation not carrying the transgene

Allelic Composition	Gkn2^{tm1.1(KOMP)Vlcg}/Gkn2^{tm1.1(KOMP)Vlcg} Il6st^tm1Ern/Il6st^tm1Ern
Genetic Background	involves: 129S1/Sv * C57BL/6NTac

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gkn2^{tm1.1(KOMP)Vlcg} mutation (1 available); any Gkn2 mutation (22 available)
Il6st^tm1Ern mutation (13 available); any Il6st mutation (80 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

digestive/alimentary system

abnormal stomach mucosa morphology ( J:234656 )

• corpus tumors display poorly differentiated and hyperplastic epithelium histologically

increased stomach mucosa thickness ( J:234656 )

• in the corpus mucosa as a result of tumor formation

• however, antral mucosa thickness is similar to Il6st single mutants

increased stomach tumor incidence ( J:234656 )

• unlike Il6st single mutants which develop primarily antral tumors, double mutants show extensive focal tumorigenesis of the corpus and squamous epithelium overlying the limiting ridge of the corpus/forestomach junction at 12 weeks of age

• increase in both the number of corpus tumor foci and macroscopic corpus tumor area

• however, antral tumor load is similar to Il6st single mutants

neoplasm

increased stomach tumor incidence ( J:234656 )

• increase in both the number of corpus tumor foci and macroscopic corpus tumor area

• however, antral tumor load is similar to Il6st single mutants

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 05/07/2024 MGI 6.23